RxDoctor Payments Data

Ronald Blum

Internal Medicine · New York, NYNPI 1336122407

Payments from drug & device makers

$137,051in general payments, 2019–2025

Across 67 payments — averaging $2045.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$82K
  • Bayer$23K
  • Pfizer$20K
  • Boehringer Ingelheim International GmbH$12K
  • Incyte Corporation$55
$158,494in research payments, 2019–2025

Across 45 payments — averaging $3522.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$124K
  • Boehringer Ingelheim International GmbH$16K
  • Bayer$10K
  • Ipsen Innovation$4K
  • Biontech SE$3K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K

What the payments were for

  • Consulting fees$136,996100%
  • Food & beverage$550%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck42$82,260
Bayer16$22,515
Pfizer3$20,471
Boehringer Ingelheim International GmbH5$11,750
Incyte Corporation1$55

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$137,051 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York

Other internal medicine in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →